Asia Leechdom Holding COrporation: Exhibit 10.23 - Filed by newsfilecorp.com






Exhibit 10.23

Equity Transfer Agreement 

Keytech Holding Inc. (the acquirer, herein referred to as the
“Party A”) and the original shareholder Xuecheng Xia with Tianjin Boai
Pharmaceutical Co., Ltd. (the acquiree, herein referred to as the “Party B”)
have made this Equity Transfer Agreement. 

Party A: Keytech Holding Inc.

Address: 45 Old Millstone Drive, Unit #6, East Windsor, NJ 08520 
Legal
Representative: Chenghai Du 
Title: Chairman 
Nationality: Dominica 

Party B: Xuecheng Xia (shareholder of
Tianjin Boai Pharmaceutical Co., Ltd.) 
Nationality: P.R. China 
ID:
120103560326264 

	1. 	
      Party B shall transfer her equity of Tianjin Boai
      Pharmaceutical Co., Ltd., which is equal to 81.4%, to Party A and furnish
      all legal documents for this equity transfer. 

	2. 	
      Party A shall pay RMB 7 million to Party B for acquiring
      Party B’s equity. 

	3. 	
      Party A shall make the payment in a single transaction to
      Party B within the six months since this agreement is made. Party A shall
      transfer the payment to Party B’s account in Bank of China. The payment is
      denominated in U.S. Dollars according to the exchange rate published by
      the State Administration of Foreign Exchange of P.R. China on the payment
      date. 

	4. 	
      (1) Party A shall pay for the acquired equity to Party B
      in full amount in time according to this agreement. 

		
      (2) Party A shall seal the acquisition and provide the
      following documents for the incorporation of foreign-funded enterprise.
      



	 	a. 	Agreement and Regulations of the foreign-funded enterprise after
      equity transfer. 
	 	b. 	Party A’s incorporation document and credit standing document. 
	 	c. 	Party A’s business operation statement. 
	 	d. 	Party A’s business license copy. 


	5. 	
      (1) Party B shall provide the resolution to equity
      transfer agreement to Party A. 

		
      (2) Party B shall handle the transferring of equity.
    

		
      (3) Party B shall provide audited financial statements of
      the past three years to Party A. 

		
      (4) Party B shall provide business operation statement.
      

		
      (5) Party B shall provide the application for legally
      changing and incorporating the foreign-funded enterprise.
  







(6) Party B shall provide business license copy. 

6. (1) Party A shall pay the late fee of 1% of the total
payment every month if Party B does not receive the full amount of payment in 15
days after the agreed payment date referred to the terms in 3. Party A shall pay
the late fee of 3% of the total payment every month and any loses if Party B
does not receive the full amount of payment in three months after the agreed
payment date referred to the terms in 3. If any party failed to fulfill and
execute this Agreement, the liable party should make compensation to the other.


(2) Party A and Party B shall negotiate for settlement when
default or misinterpretation in connection to this Agreement happens. If failed
to negotiate for settlement, Party A and Party B could submit their dispute for
binding arbitration to Party B’s local court. 

7. This agreement is governed by the laws of P.R. China. 

8. (1) This Agreement is written in Chinese and English. The
final interpretation of the Chinese Agreement shall prevail. 

(2) The changing and supplementing of this Agreement shall be
agreed by both parties and have the same legal enforcement as this Agreement.


(3) Matters not provided for in this Agreement, by “The
Business Laws of Foreign Joint Ventures of P.R. China”, shall be decided through
mutual consultation.

(4) Each Party has a copy of this Agreement. 

Party A: 

Legal Representative Signature: 

Party B: Xuecheng Xia (shareholder of Tianjin Boai
Pharmaceutical Co., Ltd.) 

Signature: 

Date: July 5, 2007